- Academic Registry
Course & Unit Catalogues


SL30049: Cancer therapeutics (BB30230)

[Page last updated: 26 October 2023]

Academic Year: 2023/24
Owning Department/School: Department of Life Sciences
Credits: 6 [equivalent to 12 CATS credits]
Notional Study Hours: 120
Level: Honours (FHEQ level 6)
Period:
Semester 2
Assessment Summary: CW 100%
Assessment Detail:
  • BB30230 Coursework (CW 100%)
Supplementary Assessment:
BB30230 Re-assessment Essay (where allowed by programme regulations)
Requisites: Before taking this module you are advised to take BB20023 OR take SL20003
Learning Outcomes: After taking this course the student should be able to:
* Demonstrate a thorough knowledge of the molecular and microenvironmental differences between cancer and normal tissues
* Explain how these differences are exploited in drug design for cancer treatment
* Critically evaluate current and emerging therapies against cancer.


Aims: To provide students with:
* A thorough understanding of the scientific basis underlying the principles and practice of cancer therapeutics
* A critical overview of the biology behind the development and evaluation of current and emerging treatments for cancer.

Skills: Learning and studying T/F/A, information handling and retrieval T/F/A, working independently T/F, written communication T/F/A, oral communication T/F/A.

Content: Molecular and cellular cancer pathways associated with the tumour microenvironment or growth, which underpin current cancer treatments including;
* Genetic screening
* Radiotherapy, chemotherapy and adjuvant therapies
* Emerging therapies such as immunotherapy, angiotherapy and other small molecule therapies based on the translation of innovative cancer biology research into lead and preclinical stage drug candidates.

Course availability:

SL30049 is Optional on the following courses:

Department of Life Sciences
  • USSL-AFB01 : BSc(Hons) Biochemistry (Year 3)
  • USSL-AKB01 : BSc(Hons) Biochemistry with Professional Placement (Year 4)
  • USSL-AFB03 : BSc(Hons) Biomedical Sciences (Year 3)
  • USSL-AKB03 : BSc(Hons) Biomedical Sciences with Professional Placement (Year 4)
  • USSL-AFM01 : MBiochem(Hons) Biochemistry (Year 3)
  • USSL-AKM01 : MBiochem(Hons) Biochemistry with Professional Placement (Year 4)
  • USSL-AFM03 : MBioMed(Hons) Biomedical Sciences (Year 3)
  • USSL-AKM03 : MBioMed(Hons) Biomedical Sciences with Professional Placement (Year 4)

Notes:

  • This unit catalogue is applicable for the 2023/24 academic year only. Students continuing their studies into 2024/25 and beyond should not assume that this unit will be available in future years in the format displayed here for 2023/24.
  • Courses and units are subject to change in accordance with normal University procedures.
  • Availability of units will be subject to constraints such as staff availability, minimum and maximum group sizes, and timetabling factors as well as a student's ability to meet any pre-requisite rules.
  • Find out more about these and other important University terms and conditions here.